[Truncated from the Portfolio Update article in the 6/16/2015 issue of Smart Tech Investor]The role of customer service is evolving. Zendesk (ZEN), provider of a cloud-based customer service software platform, is one promising vendor leading the charge to improve how businesses interact with their customers. I am adding… Read More
Archive
Filter
[Truncated from the Portfolio Update article in the 6/16/2015 issue of Smart Tech Investor]The role of customer service is evolving. Zendesk (ZEN), provider of a cloud-based customer service software platform, is one promising vendor leading the charge to improve how businesses interact with their customers. I am adding… Read More
We are adding Zendesk to the Next Wave Portfolio with a buy limit of $25, and a stop loss of $19.50. Read More
Citrix could realize significant value through several alternative transaction structures, including a sale or spin-off. Read More
Today, we reveal our method for selecting portfolio recommendations using a system based on fundamental analysis of emerging biotech companies. Read More
Making money investing in the tech sector is not as easy as it may seem. While the mainstream media spends most of its time talking about the companies that have already become industry heavyweights, it spends very little time discussing those that have fallen by the wayside. Of course, as… Read More
Six months ago we identified FireEye (NSDQ: FEYE) as “The One Tech Stock to Own in 2015“, and since then its share price has done nothing but go almost straight up. On that day it closed at $28.56, and ended last week at $51.03 for a gain of 78%… Read More
Six months ago we identified FireEye (NSDQ: FEYE) as “The One Tech Stock to Own in 2015“, and since then its share price has done nothing but go almost straight up. On that day it closed at $28.56, and ended last week at $51.03 for a gain of 78%… Read More
A common criticism of tech stocks is that too many of them are "priced for perfection", but even more puzzling to us are those tech companies that appear to be priced for imperfection, such as this one. Read More
As described in today’s edition of Smart Tech 50 Weekly Movers, we are adding Neurocrine Biosciences (NSDQ: NBIX) to the STI Equity Trades Portfolio with a buy limit of $46, and a stop loss of $36. Read More